Skip to main content
Clinical Medicine logoLink to Clinical Medicine
. 2005 May 1;5(3):268–274. doi: 10.7861/clinmedicine.5-3-268

Use of antidepressant medication following acquired brain injury: concise guidance

Lynne Turner-Stokes 1,2, Ron MacWalter, a multidisciplinary Guideline Development Group convened by the British Society of Rehabilitation Medicine and the British Geriatrics Society, in association with the Royal College of Physicians, London3
PMCID: PMC4952213  PMID: 16011220

Abstract

Depression is increasingly recognised as a common sequel to acquired brain injury and the use of antidepressant medication in this context has increased markedly over recent years. However, these drugs are not without side effects – some of them serious – and they should not be used without proper evaluation and monitoring. This set of concise guidance was developed jointly by the British Society of Rehabilitation Medicine, the British Geriatrics Society and the Royal College of Physicians, to guide clinicians working with people who have brain injury of any cause (ie stroke, trauma, anoxia, infection etc). The guidance covers (a) screening and assessment of depression in the context of brain injury, (b) issues to consider and discuss with the patient and their family before starting treatment, and (c) proper treatment planning and evaluation – including planned withdrawal at the end of treatment.

Key Words: antidepressive agents, brain injuries, depression, practice guidelines

Full Text

The Full Text of this article is available as a PDF (99.7 KB).


Articles from Clinical Medicine are provided here courtesy of Royal College of Physicians

RESOURCES